Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 28.59% is 36% above its 5-year average of 21.02%, near the high end of its 5-year range (6.83%–30.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.29% above its 12-month average of 19.81%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 28.59%.
DEBT TO ASSETS RATIO
28.59%
DEBT TO ASSETS RATIO AVG TTM
19.81%
DEBT TO ASSETS RATIO AVG 3Y
25.97%
DEBT TO ASSETS RATIO AVG 5Y
21.02%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+44.29%
CURRENT VS 3Y AVG
+10.07%
CURRENT VS 5Y AVG
+35.97%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+31662.59%
vs the sector median at left
Alpha Teknova, Inc.
Market Cap
$469.12M
Debt to Assets Ratio
28.59%
TTM Avg
19.81%
3Y Avg
25.97%
5Y Avg
21.02%
Market Cap
$472.23M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$465.75M
Debt to Assets Ratio
0.40%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$475.91M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$483.54M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | $469.12M | 28.59% | 19.81% | 25.97% | 21.02% |
| Kamada Ltd. (KMDA)vs › | $467.90M | 0.03% | N/A | N/A | N/A |
| Cerus Corporation (CERS)vs › | $471.57M | 0.37% | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $471.65M | 0.01% | N/A | N/A | N/A |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.23M | 0.00% | N/A | N/A | N/A |
| Sight Sciences, Inc. (SGHT)vs › | $465.75M | 0.40% | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $475.91M | 0.03% | N/A | N/A | N/A |
| Puma Biotechnology, Inc. (PBYI)vs › | $483.54M | 0.02% | N/A | N/A | N/A |
| NRC Health (NRC)vs › | $452.54M | 0.66% | N/A | N/A | N/A |
| Evolus, Inc. (EOLS)vs › | $486.01M | 0.66% | N/A | N/A | N/A |
Debt/Assets
28.6%
Debt/Equity
0.44
Current Ratio
4.49
Interest Coverage
-23.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 28.59% |
| 2026-03-31 | 14.86% |
| 2025-12-31 | 14.62% |
| 2025-09-30 | 14.78% |
| 2025-06-30 | 26.22% |
| 2025-03-31 | 25.74% |
| 2024-12-31 | 25.40% |
| 2024-09-30 | 24.65% |
| 2024-06-30 | 26.85% |
| 2024-03-31 | 25.96% |
| 2023-12-31 | 23.69% |
| 2023-09-30 | 22.26% |
| 2023-06-30 | 30.36% |
| 2023-03-31 | 29.02% |
| 2022-12-31 | 27.79% |
| 2022-09-30 | 22.44% |
| 2022-06-30 | 19.99% |
| 2022-03-31 | 17.36% |
| 2021-12-31 | 7.13% |
| 2021-09-30 | 6.99% |
| 2021-06-30 | 6.83% |
| 2021-03-31 | 15.42% |
| 2020-12-31 | 0.00% |
